Hyeri Park

1.2k total citations
53 papers, 923 citations indexed

About

Hyeri Park is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hyeri Park has authored 53 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hyeri Park's work include Forensic Toxicology and Drug Analysis (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Opioid Use Disorder Treatment (4 papers). Hyeri Park is often cited by papers focused on Forensic Toxicology and Drug Analysis (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Opioid Use Disorder Treatment (4 papers). Hyeri Park collaborates with scholars based in South Korea, United States and Netherlands. Hyeri Park's co-authors include Seung Ju Lee, Youhoon Chong, Hyunah Choo, Mi Kyoung Kim, Jiyong Hong, Min Jung Kim, Kwang‐Su Park, Youn‐Kwan Jung, Seung Woo Han and Min Su Han and has published in prestigious journals such as Cell, Nature Communications and Scientific Reports.

In The Last Decade

Hyeri Park

50 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyeri Park South Korea 19 356 144 103 96 95 53 923
Aqeel Ahmad Saudi Arabia 20 686 1.9× 93 0.6× 107 1.0× 87 0.9× 107 1.1× 52 1.2k
Aswani Dutt Vadlapudi United States 19 706 2.0× 112 0.8× 101 1.0× 54 0.6× 166 1.7× 27 1.6k
Dong Young Kang South Korea 19 521 1.5× 63 0.4× 66 0.6× 88 0.9× 196 2.1× 55 1.2k
Jialu Huang China 16 350 1.0× 65 0.5× 64 0.6× 83 0.9× 62 0.7× 52 1.0k
Wenjie Wang China 19 525 1.5× 93 0.6× 219 2.1× 221 2.3× 78 0.8× 87 1.3k
Sumel Ashique India 22 553 1.6× 45 0.3× 256 2.5× 54 0.6× 147 1.5× 134 1.5k
Federico Iacovelli Italy 20 685 1.9× 49 0.3× 94 0.9× 50 0.5× 50 0.5× 61 1.2k
Hemachand Tummala United States 19 341 1.0× 50 0.3× 111 1.1× 72 0.8× 96 1.0× 31 935
Ashish Garg India 21 660 1.9× 154 1.1× 229 2.2× 83 0.9× 115 1.2× 82 1.4k
Gamaleldin I. Harisa Saudi Arabia 23 506 1.4× 90 0.6× 223 2.2× 88 0.9× 139 1.5× 88 1.5k

Countries citing papers authored by Hyeri Park

Since Specialization
Citations

This map shows the geographic impact of Hyeri Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyeri Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyeri Park more than expected).

Fields of papers citing papers by Hyeri Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyeri Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyeri Park. The network helps show where Hyeri Park may publish in the future.

Co-authorship network of co-authors of Hyeri Park

This figure shows the co-authorship network connecting the top 25 collaborators of Hyeri Park. A scholar is included among the top collaborators of Hyeri Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyeri Park. Hyeri Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wright, Nicholas J., Hyeri Park, Wei He, et al.. (2024). Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain relief. Nature Communications. 15(1). 10738–10738. 1 indexed citations
2.
Han, Ji Woong, Hyeri Park, Chan‐Sik Kim, et al.. (2024). Achyranthis radix Extract Enhances Antioxidant Effect of Placenta-Derived Mesenchymal Stem Cell on Injured Human Ocular Cells. Cells. 13(14). 1229–1229. 1 indexed citations
3.
Lee, Ja-Rang, Hyeri Park, Yun-Jung Lee, et al.. (2024). Transcriptome analysis of cynomolgus macaques throughout their lifespan reveals age-related immune patterns. PubMed. 10(1). 30–30.
4.
Kim, Gun-Woo, Hyeri Park, Gabbine Wee, et al.. (2024). CXCR4 in articular chondrocyte may have a protective effect on advanced knee osteoarthritis. Osteoarthritis and Cartilage. 32. S439–S440. 2 indexed citations
5.
Park, Hyeri, et al.. (2024). Discovery of PLD4 modulators by high-throughput screening and kinetic analysis. Results in Chemistry. 7. 101349–101349.
6.
Lin, Lucy, et al.. (2024). Investigations of Thiosemicarbazides as Botulinum Toxin Active-Site Inhibitors: Enzyme, Cellular, and Rodent Intoxication Studies. ACS Infectious Diseases. 10(11). 3744–3750. 1 indexed citations
7.
Kim, Sungjun, Hee Won Park, Ashok Kumar Jangid, et al.. (2024). Amphiphilic lipid conjugate-mediated surface engineering of placenta-derived mesenchymal stem cells for alleviating liver damage and fibrosis. Chemical Engineering Journal. 503. 158313–158313. 5 indexed citations
8.
Park, Hyeri, et al.. (2022). A Vaccine against Benzimidazole-Derived New Psychoactive Substances That Are More Potent Than Fentanyl. Journal of Medicinal Chemistry. 65(3). 2522–2531. 12 indexed citations
9.
Park, Hyeri, et al.. (2021). Synthetic efforts toward the bicyclo[3.2.1]octane fragment of rhodojaponin III. Tetrahedron Letters. 71. 153055–153055. 5 indexed citations
10.
Park, Hyeri, et al.. (2021). Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin. Bioorganic & Medicinal Chemistry. 41. 116225–116225. 8 indexed citations
11.
Park, Hyeri, et al.. (2020). A single mutation in the ACTR8 gene associated with lineage-specific expression in primates. BMC Evolutionary Biology. 20(1). 66–66. 7 indexed citations
12.
Wojtaszek, Jessica L., Nimrat Chatterjee, Javaria Najeeb, et al.. (2019). A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy. Cell. 178(1). 152–159.e11. 131 indexed citations
13.
Jung, Youn‐Kwan, Hyeri Park, Hyun‐Jung Cho, et al.. (2019). Degrading products of chondroitin sulfate can induce hypertrophy-like changes and MMP-13/ADAMTS5 production in chondrocytes. Scientific Reports. 9(1). 15846–15846. 31 indexed citations
14.
Kwon, Do-Yeon, Kiyoun Lee, Hyeri Park, Mi Jung Kim, & Jiyong Hong. (2018). Synthetic efforts towards the stereoselective synthesis of NF00659B1. Bioorganic & Medicinal Chemistry Letters. 28(16). 2746–2750. 6 indexed citations
15.
Kim, YoungJae, Hyeri Park, Jinsung Tae, et al.. (2016). 5-HT 7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity. European Journal of Medicinal Chemistry. 123. 180–190. 14 indexed citations
16.
Kwon, Hyung‐Min, Jae‐Sung Lim, Young Seo Kim, et al.. (2014). Cerebral microbleeds are associated with nocturnal reverse dipping in hypertensive patients with ischemic stroke. BMC Neurology. 14(1). 8–8. 19 indexed citations
17.
Park, Hyeri, Keehyuk Kim, & Seung Ju Lee. (2013). Adjustment of Arrhenius activation energy of laccase-based time–temperature integrator (TTI) using sodium azide. Food Control. 32(2). 615–620. 29 indexed citations
18.
Park, Hyeri, et al.. (2012). Application of a Prototype of Microbial Time Temperature Indicator (TTI) to the Prediction of Ground Beef Qualities during Storage. Korean Journal for Food Science of Animal Resources. 32(4). 448–457. 28 indexed citations
19.
Park, Suyeon, et al.. (2011). Intrathecal Chemotherapy Related Myelopathy Improved with Folate and Cyanocobalamin. Journal of the Korean Neurological Association. 29(3). 224–226. 4 indexed citations
20.
Kim, Mi Kyoung, Hyeri Park, Kyung Bo Kim, et al.. (2011). 2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV). European Journal of Medicinal Chemistry. 46(11). 5698–5704. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026